Charles E. Diliberti
5Patents
2h-index
8Co-inventors
36Inventor score
Filing activity: May 26, 2006 → Jun 8, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8415332B2 | Methods of hormonal treatment utilizing ascending-dose extended cycle regimens | Human Necessities | 54 | Active |
| US8663681B2 | Oral dosage forms comprising progesterone and methods of making and using the same | Human Necessities | 51 | Active |
| US8450299B2 | Methods of hormonal treatment utilizing ascending-dose extended cycle regimens | Human Necessities | 1 | Active |
| US9220692B2 | Methods of reducing symptoms in subjects using single dosage forms with tapering release rates | Human Necessities | 0 | Active |
| US7833724B2 | Methods for comparing the immunogenicity of products and uses thereof | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.